ModelEdge

DMK Pharmaceuticals Corp
DMK
Filing Type10-K/A
Filing Date9/19/2022
Updated9/20/22, 11:06 AM

Filing

10-K/A
Earnings Release

Exhibits

10-K/AFY 2021 amended
EX-31.1CERTIFICATION BY CEO PURSUANT TO SECTION 302
EX-31.2CERTIFICATION BY CFO PURSUANT TO SECTION 302
EX-32.1CERTIFICATION BY CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
EX-32.2CERTIFICATION BY CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002